Ann: NYR-BI03 Phase Ia Clinical Trial Update - Correction, page-17

  1. 1,231 Posts.
    lightbulb Created with Sketch. 157
    disregard him mate. It’s following the chart for the next run up. Absolutely stupid market cap of 19 million with a company having 8 million in cash and the fundamentals with 6 years of derisking and now out of the preclinical setting with fundamentals that are amazing and about to start human trials next month with ethics submission this month. The traders are lining this up for Jan and accumulating the idiots that are giving them entry points. Just plain stupid.

    3 weeks to go until Walter Reed and any good news progresses joint venture with the US Army which leads us straight into first human dosing
    Last edited by Bendunstan: 18/12/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
23.5¢
Change
0.015(6.82%)
Mkt cap ! $49.56M
Open High Low Value Volume
22.5¢ 23.5¢ 22.5¢ $44.23K 194.4K

Buyers (Bids)

No. Vol. Price($)
1 50000 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 102320 1
View Market Depth
Last trade - 15.35pm 25/06/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.